|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 5 of 50 found articles
| Title: |
A randomized phase 2 trial of azacitidine with or without durvalumab as first-line therapy for higher-risk myelodysplastic syndromes |
| Author: |
Zeidan, Amer M. Boss, Isaac Beach, C.L. Copeland, Wilbert B. Thompson, Ethan Fox, Brian A. Hasle, Vanessa E. Ogasawara, Ken Cavenagh, James Silverman, Lewis R. Voso, Maria Teresa Hellmann, Andrzej Tormo, Mar O'Connor, Tim Previtali, Alessandro Rose, Shelonitda Garcia-Manero, Guillermo |
| Appeared in: |
Blood advances |
| Paging: | Volume 6 () nr. 7 pages 2207-2218 |
| Year: |
2022 |
| Contents: | |
| Publisher: |
The American Society of Hematology |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 5 of 50 found articles
| << previous | next >> |